SLPMA President Dinesh Athapaththu says pharmaceutical manufacturing can become one of next star industriesInsists on building global competitiveness by leveraging Sri Lanka’s scientific talent and proximity to IndiaOutlines five pillars for industry transformationThe Sri Lanka Pharmaceutical Manufacturers’

Seeks policy reset to unlock export potentialSector aims to transition from import substitution to a lucrative export hub by leveraging Sri Lanka’s untapped pool of science graduates Manufacturers urge the immediate removal of crippling product development taxes and

Sri Lanka pharmaceutical manufacturers have the potential to tap the global pharmaceutical industry worth USD 1.8 trillion, Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA) President Dinesh Athapaththu told the 60th SLPMA Annual General Meeting (AGM) held in Colombo